Genomics Sells Nearly 30,000 Shares: Investor Signal for Genomics Stocks
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
This guide compares the cost profiles of Index Fund and Target Date Retirement funds, highlighting where charges differ and how to choose cost-efficient options.
28,430 articlesA CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
A top executive recently moved a sizable block of Impinj stock. This article unpacks why insider sales happen, how to...
In today’s Morning Minute: Crypto Majors, a squeeze in liquidity meets geopolitical headlines, pushing major crypto a...
A veteran Wall Street voice argues that safety plus reliable income now drive retiree portfolios, spotlighting five h...
A memory-focused stock surged from about $40 to near $2,000 this year, fueling debate over whether the run can endure...
Central markets abroad account for roughly half of global market capitalization. BKIE offers ultra-low-cost access to...
Eastman Chemical is delivering a steady 4.5% dividend as a new core catalyst reshapes its cash flow, turning the comp...
SoundHound AI’s stock fell 6% to dip below $7 after the CFO resigns, with NVIDIA expanding edge AI ties. The move hig...
Palantir surged into focus after blowout Q1 results and a fresh Buy rating from Argus with a $190 target, raising que...
Kick off your week with a concise, practical set of market notes. This Tuesday reads guide blends data, strategy, and...
Trump rejects Kurdish involvement in Iran war, triggering cautious moves in oil, equities, and currencies as markets ...